The thirty-sixth meeting of the Emergency Committee under the International Health Regulations (IHR) (2005) regarding the international spread of wild poliovirus, was convened by the WHO Director-General on 16 August 2023.
The committee agreed that the situation still constitutes a Public Health Emergency of International Concern (PHEIC) and recommended the extension of the temporary recommendations.
Under IHR (2005), proof of polio vaccination recorded on an International Certificate of Vaccination or Prophylaxis (ICVP), given 4 weeks to 12 months before departure, may be required on exit from the following countries:
The global situation with polio virus is ongoing and TRAVAX users are urged to check the polio vaccination recommendations and documentation requirements on individual country pages.
Travellers should be encouraged to take strict precautions with food, water and personal hygiene. See the TRAVAX poliomyelitis page for further information.
In order to comply with the latest WHO temporary recommendations and also to avoid travellers receiving live oral polio vaccine unnecessarily when departing polio-infected countries, TRAVAX has made the following vaccination recommendations:
The ICVP is the yellow booklet normally used for yellow fever vaccination. Failure to produce an ICVP when departing a polio-endemic country may result in the traveller being vaccinated on their departure, often using live oral polio vaccine. This may cause problems for individuals with weakened immune systems (including pregnancy) who should NOT receive live oral polio vaccine.
Paper ICVP’s can be obtained from Public Health Scotland (PHS) by contacting TRAVAX administration:
Rest of UK:
Paper ICVP’s should be obtained from NaTHNaC: